1
|
Stone RA, Tobias JW, Wei W, Carlstedt X, Zhang L, Iuvone PM, Nickla DL. Diurnal gene expression patterns in retina and choroid distinguish myopia progression from myopia onset. PLoS One 2024; 19:e0307091. [PMID: 39028695 PMCID: PMC11259283 DOI: 10.1371/journal.pone.0307091] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2024] [Accepted: 06/30/2024] [Indexed: 07/21/2024] Open
Abstract
The world-wide prevalence of myopia (nearsightedness) is increasing, but its pathogenesis is incompletely understood. Among many putative mechanisms, laboratory and clinical findings have implicated circadian biology in the etiology of myopia. Consistent with a circadian hypothesis, we recently reported a marked variability in diurnal patterns of gene expression in two crucial tissues controlling post-natal refractive development - the retina and choroid-at the onset of form-deprivation myopia in chick, a widely studied and validated model. To extend these observations, we assayed gene expression by RNA-Seq in retina and choroid during the progression of established unilateral form-deprivation myopia of chick. We assayed gene expression every 4 hours during a single day from myopic and contralateral control eyes. Retinal and choroidal gene expression in myopic vs. control eyes during myopia progression differed strikingly at discrete times during the day. Very few differentially expressed genes occurred at more than one time in either tissue during progressing myopia. Similarly, Gene Set Enrichment Analysis pathways varied markedly by time during the day. Some of the differentially expressed genes in progressing myopia coincided with candidate genes for human myopia, but only partially corresponded with genes previously identified at myopia onset. Considering other laboratory findings and human genetics and epidemiology, these results further link circadian biology to the pathogenesis of myopia; but they also point to important mechanistic differences between the onset of myopia and the progression of established myopia. Future laboratory and clinical investigations should systematically incorporate circadian mechanisms in studying the etiology of myopia and in seeking more effective treatments to normalize eye growth in children.
Collapse
Affiliation(s)
- Richard A. Stone
- Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America
| | - John W. Tobias
- Penn Genomics and Sequencing Core, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America
| | - Wenjie Wei
- Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America
| | - Xia Carlstedt
- Department of Biomedical Sciences and Disease, New England College of Optometry, Boston, Massachusetts, United States of America
| | - Lixin Zhang
- Department of Biomedical Sciences and Disease, New England College of Optometry, Boston, Massachusetts, United States of America
| | - P. Michael Iuvone
- Department of Ophthalmology & Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, Georgia, United States of America
| | - Debora L. Nickla
- Department of Biomedical Sciences and Disease, New England College of Optometry, Boston, Massachusetts, United States of America
| |
Collapse
|
2
|
Ye L, Guo YM, Cai YX, Wei J, Huang J, Bi J, Chen D, Li FF, Huang XF. Trio-based whole-exome sequencing reveals mutations in early-onset high myopia. BMJ Open Ophthalmol 2024; 9:e001720. [PMID: 38789272 PMCID: PMC11129018 DOI: 10.1136/bmjophth-2024-001720] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2024] [Accepted: 05/12/2024] [Indexed: 05/26/2024] Open
Abstract
PURPOSE Myopia, especially high myopia (HM), represents a widespread visual impairment with a globally escalating prevalence. This study aimed to elucidate the genetic foundations associated with early-onset HM (eoHM) while delineating the genetic landscape specific to Shaanxi province, China. METHODS A comprehensive analysis of whole-exome sequencing was conducted involving 26 familial trios displaying eoHM. An exacting filtration protocol identified potential candidate mutations within acknowledged myopia-related genes and susceptibility loci. Subsequently, computational methodologies were employed for functional annotations and pathogenicity assessments. RESULTS Our investigation identified 7 genes and 10 variants associated with HM across 7 families, including a novel mutation in the ARR3 gene (c.139C>T, p.Arg47*) and two mutations in the P3H2 gene (c.1865T>C, p.Phe622Ser and c.212T>C, p.Leu71Pro). Pathogenic mutations were found in syndromic myopia genes, notably encompassing VPS13B, TRPM1, RPGR, NYX and RP2. Additionally, a thorough comparison of previously reported causative genes of syndromic myopia and myopia risk genes with the negative sequencing results pinpointed various types of mutations within risk genes. CONCLUSIONS This investigation into eoHM within Shaanxi province adds to the current understanding of myopic genetic factors. Our results warrant further functional validation and ocular examinations, yet they provide foundational insights for future genetic research and therapeutic innovations in HM.
Collapse
Affiliation(s)
- Lu Ye
- Shaanxi Eye Hospital, Xi'an People's Hospital (Xi'an Fourth Hospital), Affiliated People's Hospital of Northwest University, Xi'an, Shaanxi, China
| | - Yi-Ming Guo
- Shaanxi Eye Hospital, Xi'an People's Hospital (Xi'an Fourth Hospital), Affiliated People's Hospital of Northwest University, Xi'an, Shaanxi, China
| | - Yi-Xin Cai
- Zhejiang Provincial Clinical Research Center for Pediatric Disease, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
| | - Junhan Wei
- Shaanxi Eye Hospital, Xi'an People's Hospital (Xi'an Fourth Hospital), Affiliated People's Hospital of Northwest University, Xi'an, Shaanxi, China
| | - Juan Huang
- Shaanxi Eye Hospital, Xi'an People's Hospital (Xi'an Fourth Hospital), Affiliated People's Hospital of Northwest University, Xi'an, Shaanxi, China
| | - Jiejing Bi
- Shaanxi Eye Hospital, Xi'an People's Hospital (Xi'an Fourth Hospital), Affiliated People's Hospital of Northwest University, Xi'an, Shaanxi, China
| | - Ding Chen
- National Clinical Research Center for Ocular Diseases, Wenzhou Medical University Eye Hospital, Wenzhou, Zhejiang, China
- State Key Laboratory of Ophthalmology Optometry and Visual Science, Wenzhou Medical University Eye Hospital, Wenzhou, Zhejiang, China
| | - Fen-Fen Li
- National Clinical Research Center for Ocular Diseases, Wenzhou Medical University Eye Hospital, Wenzhou, Zhejiang, China
- State Key Laboratory of Ophthalmology Optometry and Visual Science, Wenzhou Medical University Eye Hospital, Wenzhou, Zhejiang, China
| | - Xiu-Feng Huang
- Zhejiang Provincial Clinical Research Center for Pediatric Disease, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
| |
Collapse
|
3
|
Taye N, Redhead C, Hubmacher D. Secreted ADAMTS-like proteins as regulators of connective tissue function. Am J Physiol Cell Physiol 2024; 326:C756-C767. [PMID: 38284126 DOI: 10.1152/ajpcell.00680.2023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2023] [Revised: 01/23/2024] [Accepted: 01/23/2024] [Indexed: 01/30/2024]
Abstract
The extracellular matrix (ECM) determines functional properties of connective tissues through structural components, such as collagens, elastic fibers, or proteoglycans. The ECM also instructs cell behavior through regulatory proteins, including proteases, growth factors, and matricellular proteins, which can be soluble or tethered to ECM scaffolds. The secreted a disintegrin and metalloproteinase with thrombospondin type 1 repeats/motifs-like (ADAMTSL) proteins constitute a family of regulatory ECM proteins that are related to ADAMTS proteases but lack their protease domains. In mammals, the ADAMTSL protein family comprises seven members, ADAMTSL1-6 and papilin. ADAMTSL orthologs are also present in the worm, Caenorhabditis elegans, and the fruit fly, Drosophila melanogaster. Like other matricellular proteins, ADAMTSL expression is characterized by tight spatiotemporal regulation during embryonic development and early postnatal growth and by cell type- and tissue-specific functional pleiotropy. Although largely quiescent during adult tissue homeostasis, reexpression of ADAMTSL proteins is frequently observed in the context of physiological and pathological tissue remodeling and during regeneration and repair after injury. The diverse functions of ADAMTSL proteins are further evident from disorders caused by mutations in individual ADAMTSL proteins, which can affect multiple organ systems. In addition, genome-wide association studies (GWAS) have linked single nucleotide polymorphisms (SNPs) in ADAMTSL genes to complex traits, such as lung function, asthma, height, body mass, fibrosis, or schizophrenia. In this review, we summarize the current knowledge about individual members of the ADAMTSL protein family and highlight recent mechanistic studies that began to elucidate their diverse functions.
Collapse
Affiliation(s)
- Nandaraj Taye
- Orthopedic Research Laboratories, Leni & Peter W. May Department of Orthopedics, Icahn School of Medicine at Mount Sinai, New York, New York, United States
| | - Charlene Redhead
- Orthopedic Research Laboratories, Leni & Peter W. May Department of Orthopedics, Icahn School of Medicine at Mount Sinai, New York, New York, United States
| | - Dirk Hubmacher
- Orthopedic Research Laboratories, Leni & Peter W. May Department of Orthopedics, Icahn School of Medicine at Mount Sinai, New York, New York, United States
| |
Collapse
|
4
|
Yu X, Yuan J, Chen ZJ, Li K, Yao Y, Xing S, Xue Z, Zhang Y, Peng H, An G, Yu X, Qu J, Su J. Whole-Exome Sequencing Among School-Aged Children With High Myopia. JAMA Netw Open 2023; 6:e2345821. [PMID: 38039006 PMCID: PMC10692858 DOI: 10.1001/jamanetworkopen.2023.45821] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/26/2023] [Accepted: 10/17/2023] [Indexed: 12/02/2023] Open
Abstract
Importance High myopia (HM) is one of the leading causes of visual impairment worldwide. Genetic factors are known to play an important role in the development of HM. Objective To identify risk variants in a large HM cohort and to examine the implications of genetic testing of schoolchildren with HM. Design, Setting, and Participants This cohort study retrospectively reviewed whole-exome sequencing (WES) results in 6215 schoolchildren with HM who underwent genetic testing between September 2019 and July 2020 in Wenzhou City, China. HM is defined as a spherical equivalent refraction (SER) of -6.00 diopters (D) or less. The study setting was a genetic testing laboratory and a multicenter school census. Data were analyzed from July 2021 to June 2022. Main Outcomes and Measures The frequency and distribution of positive germline variants, the percentage of individuals with HM in both eyes, and subsequent variant yield for common high myopia (CHM; -8.00 D ≤ SER ≤ -6.00 D), ultra myopia (UM; -10.00 D ≤ SER < -8.00 D), and extreme myopia (EM; SER < -10.00 D). Results Of the 6215 schoolchildren with HM, 3278 (52.74%) were male. Their mean (SD) age was 14.87 (2.02) years, including 355 students in primary school, 1970 in junior high school, and 3890 in senior high school. The mean (SD) SER was -7.51 (-1.36) D for the right eye and -7.46 (-1.34) D for the left eye. Among schoolchildren with HM, genetic testing yielded 271 potential pathogenic variants in 75 HM candidate genes in 964 diagnoses (15.52%). A total of 36 known variants were found in 490 HM participants (7.88%) and 235 protein-truncating variants (PTVs) in 506 participants (8.14%). Involved variant yield was significantly positively associated with SER (Cochran-Armitage test for trend Z = 2.5492; P = .01), which ranged from 7.66% in the CHM group, 8.70% in the UM group, to 11.90% in the EM group. We also found that primary school students with EM had the highest variant yield of PTVs (8 of 35 students [22.86%]), which was 1.77 and 4.78 times that of the UM and CHM, respectively. Conclusions and Relevance In this cohort study of WES for HM, several potential pathogenic variants were identified in a substantial number of schoolchildren with HM. The high variation frequency in younger students with EM can provide clues for genetic screening and clinical examinations of HM to promote long-term follow-up assessment.
Collapse
Affiliation(s)
- Xiangyi Yu
- National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, China
- National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, China
| | - Jian Yuan
- National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, China
- National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, China
| | - Zhen Ji Chen
- National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, China
- National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, China
- Oujiang Laboratory, Zhejiang Laboratory for Regenerative Medicine, Vision and Brain Health, Wenzhou, Zhejiang, China
| | - Kai Li
- Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, China
| | - Yinghao Yao
- Oujiang Laboratory, Zhejiang Laboratory for Regenerative Medicine, Vision and Brain Health, Wenzhou, Zhejiang, China
| | - Shilai Xing
- National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, China
- National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, China
- Institute of PSI Genomics, Wenzhou, China
| | - Zhengbo Xue
- National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, China
- National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, China
| | - Yue Zhang
- National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, China
| | - Hui Peng
- National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, China
| | - Gang An
- Institute of PSI Genomics, Wenzhou, China
| | | | - Jia Qu
- National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, China
- National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, China
- Oujiang Laboratory, Zhejiang Laboratory for Regenerative Medicine, Vision and Brain Health, Wenzhou, Zhejiang, China
- Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, China
| | - Jianzhong Su
- National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, China
- National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, China
- Oujiang Laboratory, Zhejiang Laboratory for Regenerative Medicine, Vision and Brain Health, Wenzhou, Zhejiang, China
- Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, China
| |
Collapse
|
5
|
Sánchez-Cazorla E, González-Atienza C, López-Vázquez A, Arruti N, Nieves-Moreno M, Noval S, Mena R, Rodríguez-Jiménez C, Rodríguez-Solana P, González-Iglesias E, Guerrero-Carretero M, D’Anna Mardero O, Coca-Robinot J, Acal JC, Blasco J, Castañeda C, Fraile Maya J, Del Pozo Á, Gómez-Pozo MV, Montaño VEF, Dios-Blázquez LD, Rodríguez-Antolín C, Gómez-Cano MDLÁ, Delgado-Mora L, Vallespín E. Whole-Exome Sequencing of 21 Families: Candidate Genes for Early-Onset High Myopia. Int J Mol Sci 2023; 24:15676. [PMID: 37958660 PMCID: PMC10649067 DOI: 10.3390/ijms242115676] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2023] [Revised: 10/23/2023] [Accepted: 10/26/2023] [Indexed: 11/15/2023] Open
Abstract
High myopia is the most severe and pathological form of myopia. It occurs when the spherical refractive error exceeds -6.00 spherical diopters (SDs) or the axial length (AL) of the eye is greater than 26 mm. This article focuses on early-onset high myopia, an increasingly common condition that affects children under 10 years of age and can lead to other serious ocular pathologies. Through the genetic analysis of 21 families with early-onset high myopia, this study seeks to contribute to a better understanding of the role of genetics in this disease and to propose candidate genes. Whole-exome sequencing studies with a panel of genes known to be involved in the pathology were performed in families with inconclusive results: 3% of the variants found were classified as pathogenic, 6% were likely pathogenic and the remaining 91% were variants of uncertain significance. Most of the families in this study were found to have alterations in several of the proposed genes. This suggests a polygenic inheritance of the pathology due to the cumulative effect of the alterations. Further studies are needed to validate and confirm the role of these alterations in the development of early-onset high myopia and its polygenic inheritance.
Collapse
Affiliation(s)
- Eloísa Sánchez-Cazorla
- Molecular Ophthalmology Section, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain; (E.S.-C.); (C.G.-A.); (R.M.); (C.R.-J.); (P.R.-S.); (E.G.-I.); (M.V.G.-P.); (V.E.F.M.)
| | - Carmen González-Atienza
- Molecular Ophthalmology Section, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain; (E.S.-C.); (C.G.-A.); (R.M.); (C.R.-J.); (P.R.-S.); (E.G.-I.); (M.V.G.-P.); (V.E.F.M.)
| | - Ana López-Vázquez
- Department of Ophthalmology, IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain; (A.L.-V.); (N.A.); (M.N.-M.); (S.N.); (M.G.-C.); (O.D.M.); (J.C.-R.); (J.C.A.); (J.B.); (C.C.); (J.F.M.)
| | - Natalia Arruti
- Department of Ophthalmology, IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain; (A.L.-V.); (N.A.); (M.N.-M.); (S.N.); (M.G.-C.); (O.D.M.); (J.C.-R.); (J.C.A.); (J.B.); (C.C.); (J.F.M.)
- European Reference Network on Eye Diseases (ERN-EYE), Hospital Universitario La Paz, 28046 Madrid, Spain
| | - María Nieves-Moreno
- Department of Ophthalmology, IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain; (A.L.-V.); (N.A.); (M.N.-M.); (S.N.); (M.G.-C.); (O.D.M.); (J.C.-R.); (J.C.A.); (J.B.); (C.C.); (J.F.M.)
- European Reference Network on Eye Diseases (ERN-EYE), Hospital Universitario La Paz, 28046 Madrid, Spain
| | - Susana Noval
- Department of Ophthalmology, IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain; (A.L.-V.); (N.A.); (M.N.-M.); (S.N.); (M.G.-C.); (O.D.M.); (J.C.-R.); (J.C.A.); (J.B.); (C.C.); (J.F.M.)
- European Reference Network on Eye Diseases (ERN-EYE), Hospital Universitario La Paz, 28046 Madrid, Spain
| | - Rocío Mena
- Molecular Ophthalmology Section, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain; (E.S.-C.); (C.G.-A.); (R.M.); (C.R.-J.); (P.R.-S.); (E.G.-I.); (M.V.G.-P.); (V.E.F.M.)
- Biomedical Research Center in the Rare Diseases Network (CIBERER), Carlos II Health Institute (ISCIII), 28029 Madrid, Spain;
| | - Carmen Rodríguez-Jiménez
- Molecular Ophthalmology Section, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain; (E.S.-C.); (C.G.-A.); (R.M.); (C.R.-J.); (P.R.-S.); (E.G.-I.); (M.V.G.-P.); (V.E.F.M.)
| | - Patricia Rodríguez-Solana
- Molecular Ophthalmology Section, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain; (E.S.-C.); (C.G.-A.); (R.M.); (C.R.-J.); (P.R.-S.); (E.G.-I.); (M.V.G.-P.); (V.E.F.M.)
| | - Eva González-Iglesias
- Molecular Ophthalmology Section, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain; (E.S.-C.); (C.G.-A.); (R.M.); (C.R.-J.); (P.R.-S.); (E.G.-I.); (M.V.G.-P.); (V.E.F.M.)
| | - Marta Guerrero-Carretero
- Department of Ophthalmology, IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain; (A.L.-V.); (N.A.); (M.N.-M.); (S.N.); (M.G.-C.); (O.D.M.); (J.C.-R.); (J.C.A.); (J.B.); (C.C.); (J.F.M.)
| | - Oriana D’Anna Mardero
- Department of Ophthalmology, IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain; (A.L.-V.); (N.A.); (M.N.-M.); (S.N.); (M.G.-C.); (O.D.M.); (J.C.-R.); (J.C.A.); (J.B.); (C.C.); (J.F.M.)
| | - Javier Coca-Robinot
- Department of Ophthalmology, IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain; (A.L.-V.); (N.A.); (M.N.-M.); (S.N.); (M.G.-C.); (O.D.M.); (J.C.-R.); (J.C.A.); (J.B.); (C.C.); (J.F.M.)
| | - Juan Carlos Acal
- Department of Ophthalmology, IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain; (A.L.-V.); (N.A.); (M.N.-M.); (S.N.); (M.G.-C.); (O.D.M.); (J.C.-R.); (J.C.A.); (J.B.); (C.C.); (J.F.M.)
| | - Joana Blasco
- Department of Ophthalmology, IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain; (A.L.-V.); (N.A.); (M.N.-M.); (S.N.); (M.G.-C.); (O.D.M.); (J.C.-R.); (J.C.A.); (J.B.); (C.C.); (J.F.M.)
| | - Carlos Castañeda
- Department of Ophthalmology, IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain; (A.L.-V.); (N.A.); (M.N.-M.); (S.N.); (M.G.-C.); (O.D.M.); (J.C.-R.); (J.C.A.); (J.B.); (C.C.); (J.F.M.)
| | - Jesús Fraile Maya
- Department of Ophthalmology, IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain; (A.L.-V.); (N.A.); (M.N.-M.); (S.N.); (M.G.-C.); (O.D.M.); (J.C.-R.); (J.C.A.); (J.B.); (C.C.); (J.F.M.)
| | - Ángela Del Pozo
- Biomedical Research Center in the Rare Diseases Network (CIBERER), Carlos II Health Institute (ISCIII), 28029 Madrid, Spain;
- Clinical Bioinformatics Section, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, CIBERER, Hospital Universitario La Paz, 28046 Madrid, Spain; (L.D.D.-B.); (C.R.-A.)
| | - María V. Gómez-Pozo
- Molecular Ophthalmology Section, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain; (E.S.-C.); (C.G.-A.); (R.M.); (C.R.-J.); (P.R.-S.); (E.G.-I.); (M.V.G.-P.); (V.E.F.M.)
- Biomedical Research Center in the Rare Diseases Network (CIBERER), Carlos II Health Institute (ISCIII), 28029 Madrid, Spain;
| | - Victoria E. F. Montaño
- Molecular Ophthalmology Section, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain; (E.S.-C.); (C.G.-A.); (R.M.); (C.R.-J.); (P.R.-S.); (E.G.-I.); (M.V.G.-P.); (V.E.F.M.)
- Biomedical Research Center in the Rare Diseases Network (CIBERER), Carlos II Health Institute (ISCIII), 28029 Madrid, Spain;
| | - Lucía De Dios-Blázquez
- Clinical Bioinformatics Section, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, CIBERER, Hospital Universitario La Paz, 28046 Madrid, Spain; (L.D.D.-B.); (C.R.-A.)
| | - Carlos Rodríguez-Antolín
- Clinical Bioinformatics Section, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, CIBERER, Hospital Universitario La Paz, 28046 Madrid, Spain; (L.D.D.-B.); (C.R.-A.)
| | - María de Los Ángeles Gómez-Cano
- Clinical Genetics Section, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, CIBERER, Hospital Universitario La Paz, 28046 Madrid, Spain; (M.d.L.Á.G.-C.); (L.D.-M.)
| | - Luna Delgado-Mora
- Clinical Genetics Section, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, CIBERER, Hospital Universitario La Paz, 28046 Madrid, Spain; (M.d.L.Á.G.-C.); (L.D.-M.)
| | - Elena Vallespín
- Molecular Ophthalmology Section, Medical and Molecular Genetics Institute (INGEMM) IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain; (E.S.-C.); (C.G.-A.); (R.M.); (C.R.-J.); (P.R.-S.); (E.G.-I.); (M.V.G.-P.); (V.E.F.M.)
- European Reference Network on Eye Diseases (ERN-EYE), Hospital Universitario La Paz, 28046 Madrid, Spain
- Biomedical Research Center in the Rare Diseases Network (CIBERER), Carlos II Health Institute (ISCIII), 28029 Madrid, Spain;
| |
Collapse
|
6
|
Liu Y, Liu Y, Zhang W, Xue ZQ, Zhang FX, Xu WG, Zhuang WJ. Screening of genes interacting with high myopia and neuropsychiatric disorders. Sci Rep 2023; 13:18347. [PMID: 37884635 PMCID: PMC10603034 DOI: 10.1038/s41598-023-45463-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2023] [Accepted: 10/19/2023] [Indexed: 10/28/2023] Open
Abstract
Clinical studies have demonstrated an association between high myopia (HM) and neuropsychiatric disorders; however, the underlying mechanism of the association is not clear. We used whole exome sequencing (WES) in combination with the Genetic Variants Classification Criteria and Guidelines published by the American College of Medical Genetics (ACMG) and bioinformatics analysis to clarify the interrelationship between candidate genes. Causative genes for ocular diseases (45.38%) followed by neuropsychiatric disorders (22.69%) accounted for the highest proportion of genes that exhibited high pathogenicity in HM patients were found. Four pathogenic gene mutations were identified according to ACMG guidelines: c.164_165insACAGCA and c.C1760T in POLG, c.G1291A in COL5A1, and c.G10242T in ZNF469. Three causative genes for neuropsychiatric diseases, PTPRN2, PCDH15 and CDH23, were found to fall at the HM locus. The above results suggest that these genes may interact in high myopia and neuropsychiatric diseases.
Collapse
Affiliation(s)
- Yang Liu
- People's Hospital of Ningxia Hui Autonomous Region (Ningxia Eye Hospital), Yinchuan, China
| | - Yang Liu
- People's Hospital of Ningxia Hui Autonomous Region (Ningxia Eye Hospital), Yinchuan, China
| | - Wen Zhang
- People's Hospital of Ningxia Hui Autonomous Region (Ningxia Eye Hospital), Yinchuan, China
| | - Zhong-Qi Xue
- Department of Ophthalmology, Affiliated Hospital of Qingdao Binhai University, Qingdao, China
| | - Fang-Xia Zhang
- People's Hospital of Ningxia Hui Autonomous Region (Ningxia Eye Hospital), Yinchuan, China
| | - Wei-Gang Xu
- People's Hospital of Ningxia Hui Autonomous Region (Ningxia Eye Hospital), Yinchuan, China.
| | - Wen-Juan Zhuang
- People's Hospital of Ningxia Hui Autonomous Region (Ningxia Eye Hospital), Yinchuan, China.
| |
Collapse
|
7
|
Ma B, Zhang W, Wang X, Jiang H, Tang L, Yang W, Kang Q, Cao J. Polymorphisms in TRIB2 and CAPRIN2 Genes Contribute to the Susceptibility to High Myopia-Induced Cataract in Han Chinese Population. Med Sci Monit 2023; 29:e937702. [PMID: 36710479 PMCID: PMC9896844 DOI: 10.12659/msm.937702] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023] Open
Abstract
BACKGROUND Myopia has been shown to be associated with many pathological complications including cataracts, and previous evidence supported that high myopia facilitates the formation of cataracts. However, no studies have identified a link between the genetic susceptibility of high myopia-induced cataracts (HMC) and the underlying genetic mechanisms. Our study aimed to determine how the TRIB2 and CAPRIN2 genes correlate to the risk of HMC. MATERIAL AND METHODS In total, we successfully recruited 3162 participants, including 1026 participants with high myopia and cataracts and 2136 controls with high myopia only. For genotyping, 22 tag single nucleotide polymorphisms (SNPs) in TRIB2 and CAPRIN2 genes were chosen. Single marker association analysis and functional effects of significant SNPs were carried out. RESULTS Strong correlation signals were captured for SNP rs890069 (χ²=22.13, P=2.55×10-6) in TRIB2 and SNP rs17739338 (χ²=16.07, P=6.10×10-5) in CAPRIN2. In patients with high myopia, the C allele at SNP rs890069 was strongly linked to cataract risk (OR [95% CI]=1.36 [1.20-1.55]). In patients with high myopia, the T allele at SNP rs17739338 was significantly related to a lower risk of cataract (OR [95% CI]=0.54 [0.40-0.74]). In different types of human tissues, SNPs rs890069 and rs17739338 were found to be significantly correlated to the levels of TRIB2 and CAPRIN2 gene expression. CONCLUSIONS Our study indicated that both TRIB2 and CAPRIN2 genes conferred the susceptibility to cataract in patients with high myopia and Chinese Han ancestry. Future research remains necessary for fully understanding the pathogenic mechanisms and genetic characteristics of cataract.
Collapse
Affiliation(s)
- Bo Ma
- Department of Ophthalmology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, PR China
| | - Wenpei Zhang
- Department of Forensic Medicine, School of Medicine and Forensics, Xi’an Jiaotong University, Xi’an, Shaanxi, PR China
| | - Xiaochen Wang
- Department of Forensic Medicine, School of Medicine and Forensics, Xi’an Jiaotong University, Xi’an, Shaanxi, PR China
| | - Huili Jiang
- Department of Ophthalmology, Xi’an Fourth Hospital, Xi’an, Shaanxi, PR China
| | - Li Tang
- Department of Ophthalmology, Xi’an Fourth Hospital, Xi’an, Shaanxi, PR China
| | - Wen Yang
- Department of Ophthalmology, Xi’an Fourth Hospital, Xi’an, Shaanxi, PR China
| | - Qianyan Kang
- Department of Ophthalmology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, PR China
| | - Juan Cao
- Department of Ophthalmology, Xi’an Fourth Hospital, Xi’an, Shaanxi, PR China
| |
Collapse
|
8
|
Yuan D, Yan T, Luo S, Huang J, Tan J, Zhang J, Zhang VW, Lan Y, Hu T, Guo J, Huang M, Zeng D. Identification and Functional Characterization of a Novel Nonsense Variant in ARR3 in a Southern Chinese Family With High Myopia. Front Genet 2021; 12:765503. [PMID: 34966409 PMCID: PMC8710690 DOI: 10.3389/fgene.2021.765503] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2021] [Accepted: 11/10/2021] [Indexed: 01/28/2023] Open
Abstract
ARR3 has been associated with X-linked, female-limited, high myopia. However, using exome sequencing (ES), we identified the first high myopia case with hemizygous ARR3-related mutation in a male patient in a Southern Chinese family. This novel truncated mutation (ARR3: c.569C>G, p.S190*) co-segregated with the disease phenotype in affected family members and demonstrated that high myopia caused by ARR3 is not X-linked, female-limited, where a complicated X-linked inheritance pattern may exist. Thus, our case expanded the variant spectrum in ARR3 and provided additional information for genetic counseling, prenatal testing, and diagnosis. Moreover, we characterized the nonsense-mediated decay of the ARR3 mutant mRNA and discussed the possible underlying pathogenic mechanisms.
Collapse
Affiliation(s)
- Dejian Yuan
- Department of Medical Genetics, Liuzhou Municipal Maternity and Child Healthcare Hospital, Liuzhou, China.,Liuzhou Key Laboratory of Birth Defects Prevention and Control, Liuzhou Municipal Maternity and Child Healthcare Hospital, Liuzhou, China
| | - Tizhen Yan
- Department of Medical Genetics, Liuzhou Municipal Maternity and Child Healthcare Hospital, Liuzhou, China.,Liuzhou Key Laboratory of Birth Defects Prevention and Control, Liuzhou Municipal Maternity and Child Healthcare Hospital, Liuzhou, China
| | - Shiqiang Luo
- Department of Medical Genetics, Liuzhou Municipal Maternity and Child Healthcare Hospital, Liuzhou, China.,Liuzhou Key Laboratory of Birth Defects Prevention and Control, Liuzhou Municipal Maternity and Child Healthcare Hospital, Liuzhou, China
| | - Jun Huang
- Department of Medical Genetics, Liuzhou Municipal Maternity and Child Healthcare Hospital, Liuzhou, China.,Liuzhou Key Laboratory of Birth Defects Prevention and Control, Liuzhou Municipal Maternity and Child Healthcare Hospital, Liuzhou, China
| | - Jianqiang Tan
- Department of Medical Genetics, Liuzhou Municipal Maternity and Child Healthcare Hospital, Liuzhou, China.,Liuzhou Key Laboratory of Birth Defects Prevention and Control, Liuzhou Municipal Maternity and Child Healthcare Hospital, Liuzhou, China
| | - Jianping Zhang
- Department of Ophthalmology, Liuzhou Municipal Maternity and Child Healthcare Hospital, Liuzhou, China
| | - Victor Wei Zhang
- AmCare Genomics Laboratory, Guangzhou, China.,Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, United States
| | - Yueyuan Lan
- Department of Ophthalmology, Liuzhou Municipal Maternity and Child Healthcare Hospital, Liuzhou, China
| | - Taobo Hu
- Center of Breast Diseases, Peking University People's Hospital, Beijing, China
| | - Jing Guo
- Reproductive Medical Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
| | - Mingwei Huang
- Aegicare (Sheznzhen) Technology Co., Ltd., Shenzhen, China
| | - Dingyuan Zeng
- Department of Gynecology, Liuzhou Municipal Maternity and Child Healthcare Hospital, Liuzhou, China
| |
Collapse
|